Impact of chronic administration of anabolic androgenic steroids and taurine on blood pressure in rats
Autor(a) principal: | |
---|---|
Data de Publicação: | 2016 |
Outros Autores: | , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Brazilian Journal of Medical and Biological Research |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2016000600706 |
Resumo: | Supraphysiological administration of anabolic androgenic steroids has been linked to increased blood pressure. The widely distributed amino acid taurine seems to be an effective depressor agent in drug-induced hypertension. The purpose of this study was to assess the impact of chronic high dose administration of nandrolone decanoate (DECA) and taurine on blood pressure in rats and to verify the potentially involved mechanisms. The study was conducted in 4 groups of 8 adult male Wistar rats, aged 14 weeks, treated for 12 weeks with: DECA (A group); vehicle (C group); taurine (T group), or with both drugs (AT group). Systolic blood pressure (SBP) was measured at the beginning of the study (SBP1), 2 (SBP2) and 3 months (SBP3) later. Plasma angiotensin-converting enzyme (ACE) activity and plasma end products of nitric oxide metabolism (NOx) were also determined. SBP3 and SBP2 were significantly increased compared to SBP1 only in the A group (P<0.002 for both). SBP2, SBP3 and ACE activity showed a statistically significant increase in the A vs C (P<0.005), andvs AT groups (P<0.05), while NOx was significantly decreased in the A and AT groups vs controls (P=0.01). ACE activity was strongly correlated with SBP3 in the A group (r=0.71, P=0.04). These findings suggest that oral supplementation of taurine may prevent the increase in SBP induced by DECA, an effect potentially mediated by angiotensin-converting enzyme. |
id |
ABDC-1_b4ad584f4bfd92c77b38aedbd8019daa |
---|---|
oai_identifier_str |
oai:scielo:S0100-879X2016000600706 |
network_acronym_str |
ABDC-1 |
network_name_str |
Brazilian Journal of Medical and Biological Research |
repository_id_str |
|
spelling |
Impact of chronic administration of anabolic androgenic steroids and taurine on blood pressure in ratsAnabolic androgenic steroidsNandrolone decanoateTaurineBlood pressureAngiotensin-converting enzymeNitric oxideSupraphysiological administration of anabolic androgenic steroids has been linked to increased blood pressure. The widely distributed amino acid taurine seems to be an effective depressor agent in drug-induced hypertension. The purpose of this study was to assess the impact of chronic high dose administration of nandrolone decanoate (DECA) and taurine on blood pressure in rats and to verify the potentially involved mechanisms. The study was conducted in 4 groups of 8 adult male Wistar rats, aged 14 weeks, treated for 12 weeks with: DECA (A group); vehicle (C group); taurine (T group), or with both drugs (AT group). Systolic blood pressure (SBP) was measured at the beginning of the study (SBP1), 2 (SBP2) and 3 months (SBP3) later. Plasma angiotensin-converting enzyme (ACE) activity and plasma end products of nitric oxide metabolism (NOx) were also determined. SBP3 and SBP2 were significantly increased compared to SBP1 only in the A group (P<0.002 for both). SBP2, SBP3 and ACE activity showed a statistically significant increase in the A vs C (P<0.005), andvs AT groups (P<0.05), while NOx was significantly decreased in the A and AT groups vs controls (P=0.01). ACE activity was strongly correlated with SBP3 in the A group (r=0.71, P=0.04). These findings suggest that oral supplementation of taurine may prevent the increase in SBP induced by DECA, an effect potentially mediated by angiotensin-converting enzyme.Associação Brasileira de Divulgação Científica2016-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2016000600706Brazilian Journal of Medical and Biological Research v.49 n.6 2016reponame:Brazilian Journal of Medical and Biological Researchinstname:Associação Brasileira de Divulgação Científica (ABDC)instacron:ABDC10.1590/1414-431x20165116info:eu-repo/semantics/openAccessRoşca,A.E.Stoian,I.Badiu,C.Gaman,L.Popescu,B.O.Iosif,L.Mirica,R.Tivig,I.C.Stancu,C.S.Căruntu,C.Voiculescu,S.E.Zăgrean,L.eng2019-03-25T00:00:00Zoai:scielo:S0100-879X2016000600706Revistahttps://www.bjournal.org/https://old.scielo.br/oai/scielo-oai.phpbjournal@terra.com.br||bjournal@terra.com.br1414-431X0100-879Xopendoar:2019-03-25T00:00Brazilian Journal of Medical and Biological Research - Associação Brasileira de Divulgação Científica (ABDC)false |
dc.title.none.fl_str_mv |
Impact of chronic administration of anabolic androgenic steroids and taurine on blood pressure in rats |
title |
Impact of chronic administration of anabolic androgenic steroids and taurine on blood pressure in rats |
spellingShingle |
Impact of chronic administration of anabolic androgenic steroids and taurine on blood pressure in rats Roşca,A.E. Anabolic androgenic steroids Nandrolone decanoate Taurine Blood pressure Angiotensin-converting enzyme Nitric oxide |
title_short |
Impact of chronic administration of anabolic androgenic steroids and taurine on blood pressure in rats |
title_full |
Impact of chronic administration of anabolic androgenic steroids and taurine on blood pressure in rats |
title_fullStr |
Impact of chronic administration of anabolic androgenic steroids and taurine on blood pressure in rats |
title_full_unstemmed |
Impact of chronic administration of anabolic androgenic steroids and taurine on blood pressure in rats |
title_sort |
Impact of chronic administration of anabolic androgenic steroids and taurine on blood pressure in rats |
author |
Roşca,A.E. |
author_facet |
Roşca,A.E. Stoian,I. Badiu,C. Gaman,L. Popescu,B.O. Iosif,L. Mirica,R. Tivig,I.C. Stancu,C.S. Căruntu,C. Voiculescu,S.E. Zăgrean,L. |
author_role |
author |
author2 |
Stoian,I. Badiu,C. Gaman,L. Popescu,B.O. Iosif,L. Mirica,R. Tivig,I.C. Stancu,C.S. Căruntu,C. Voiculescu,S.E. Zăgrean,L. |
author2_role |
author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Roşca,A.E. Stoian,I. Badiu,C. Gaman,L. Popescu,B.O. Iosif,L. Mirica,R. Tivig,I.C. Stancu,C.S. Căruntu,C. Voiculescu,S.E. Zăgrean,L. |
dc.subject.por.fl_str_mv |
Anabolic androgenic steroids Nandrolone decanoate Taurine Blood pressure Angiotensin-converting enzyme Nitric oxide |
topic |
Anabolic androgenic steroids Nandrolone decanoate Taurine Blood pressure Angiotensin-converting enzyme Nitric oxide |
description |
Supraphysiological administration of anabolic androgenic steroids has been linked to increased blood pressure. The widely distributed amino acid taurine seems to be an effective depressor agent in drug-induced hypertension. The purpose of this study was to assess the impact of chronic high dose administration of nandrolone decanoate (DECA) and taurine on blood pressure in rats and to verify the potentially involved mechanisms. The study was conducted in 4 groups of 8 adult male Wistar rats, aged 14 weeks, treated for 12 weeks with: DECA (A group); vehicle (C group); taurine (T group), or with both drugs (AT group). Systolic blood pressure (SBP) was measured at the beginning of the study (SBP1), 2 (SBP2) and 3 months (SBP3) later. Plasma angiotensin-converting enzyme (ACE) activity and plasma end products of nitric oxide metabolism (NOx) were also determined. SBP3 and SBP2 were significantly increased compared to SBP1 only in the A group (P<0.002 for both). SBP2, SBP3 and ACE activity showed a statistically significant increase in the A vs C (P<0.005), andvs AT groups (P<0.05), while NOx was significantly decreased in the A and AT groups vs controls (P=0.01). ACE activity was strongly correlated with SBP3 in the A group (r=0.71, P=0.04). These findings suggest that oral supplementation of taurine may prevent the increase in SBP induced by DECA, an effect potentially mediated by angiotensin-converting enzyme. |
publishDate |
2016 |
dc.date.none.fl_str_mv |
2016-01-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2016000600706 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2016000600706 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/1414-431x20165116 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Associação Brasileira de Divulgação Científica |
publisher.none.fl_str_mv |
Associação Brasileira de Divulgação Científica |
dc.source.none.fl_str_mv |
Brazilian Journal of Medical and Biological Research v.49 n.6 2016 reponame:Brazilian Journal of Medical and Biological Research instname:Associação Brasileira de Divulgação Científica (ABDC) instacron:ABDC |
instname_str |
Associação Brasileira de Divulgação Científica (ABDC) |
instacron_str |
ABDC |
institution |
ABDC |
reponame_str |
Brazilian Journal of Medical and Biological Research |
collection |
Brazilian Journal of Medical and Biological Research |
repository.name.fl_str_mv |
Brazilian Journal of Medical and Biological Research - Associação Brasileira de Divulgação Científica (ABDC) |
repository.mail.fl_str_mv |
bjournal@terra.com.br||bjournal@terra.com.br |
_version_ |
1754302945020608512 |